Capital to fuel product innovation, digital expansion, and R&D in India’s ₹16,000 crore pain-relief market
Zanskar, a pain-care focused premium and high-efficacy wellness brand, has raised ₹2.8 crore in a seed round of funding led by Zeropearl VC, with participation from angel investors Pawan Gupta (Founder, Fashinza), Amit Baid (Managing Partner, 10X Growth Ventures), and Nidhish Mundra (SVP, Oaktree Capital).
The funds will be deployed to expand Zanskar’s product portfolio, scale up marketing across digital platforms, and enhance distribution through both D2C and offline retail channels. A portion of the capital will also be invested in building a dedicated R&D vertical focused on chronic pain and recovery.
Born out of a personal journey of the founders, Zanskar was created to address the unmet needs of people struggling with chronic pain. The co-founders, who first met as classmates at IIT Delhi, shared a vision to build a brand that blends science with accessibility. Together, they developed proprietary, science-backed formulations for joint pain, migraines, back pain, and arthritis. Today, its flagship products, including the joint pain cream with Vitamin B6 and migraine relief roll-on with magnesium, have reached over 50,000 customers across India and emerged as category leaders online.
The timing could not be more opportune. According to industry sources, India’s pain-relief market, covering sprays, creams, and pills, has more than doubled in the last five years to around ₹16,000 crore (USD 2 billion). Analgesics and topical rubefacients alone surged from ₹6,820 crore in 2020 to nearly ₹15,905 crore in 2025, growing at an annual rate of 18 percent, almost three times faster than the overall OTC market. Unlike generic OTC products that often rely on chemical-heavy formulations, Zanskar differentiates itself by blending clinical validation with clean, effective ingredients, offering efficacy without side effects.
Anshul Mittal & Manu Mittal, Co-founders of Zanskar, jointly said, “This round is a huge validation of our belief that pain relief doesn’t need to come with a trade-off. We’re excited to partner with Zeropearl to take Zanskar to more homes across India and continue building products that actually work and that people love using.”
Speaking on the investment, Bipin Shah, Managing Partner, Zeropearl VC, said: “At Zeropearl, we look for brands that are solving real & deep problems with authenticity & innovation. Zanskar’s approach to pain care by combining science with empathy really stood out of the box for us. We believe the team is well-positioned to build a trusted and scalable brand in a category that impacts millions of people in India and overseas.”
Looking ahead, Zanskar is preparing to launch new product formats targeting arthritis and muscle recovery, alongside expanding its AI-driven physiotherapy app to deliver personalized, at-home pain management protocols. The brand is also exploring early pilots in physiotherapy-led wellness centers in select metro cities, further strengthening its full-stack approach to pain relief.
Zanskar products are currently available through the brand’s website as well as leading platforms such as Blinkit, Tata 1mg, Amazon, and Flipkart.
About Zanskar
Zanskar is a next-generation wellness brand helping Indians live pain-free, naturally and holistically. From clean, effective and science-backed products to an AI-driven physiotherapy app, Zanskar is building a full-stack pain relief ecosystem that goes beyond temporary fixes. With a growing base of loyal customers, Zanskar is on a mission to replace dependency on harsh painkillers, and redefining how India manages pain, one product and one protocol at a time.
About Zeropearl VC
Zeropearl VC is a newly launched pre-seed investment firm with a bold mission: to empower founders with conviction, speed, and unconditional portfolio support. Inspired by the belief that founders are at the heart of innovation, Zeropearl VC adopts a “Founder Only” investment thesis, emphasizing the unique drive and vision of entrepreneurs.
Leave a Reply